PublishedFebruary 20, 2020 Category Partner News Breath Therapeutics, a Zambon company, initiates BOSTON-3 and BOSTON-4, two additional clinical studies for the treatment of bronchiolitis obliterans syndrome (BOS)
PublishedDecember 16, 2019 Category Partner News Kamada Announces Enrollment of First Patient into its Pivotal Phase 3 InnovAATe Clinical Trial of Inhaled AAT for the Treatment of Alpha-1 Antitrypsin Deficiency
PublishedDecember 10, 2019 Category Publications Aerosol Pirfenidone Pharmacokinetics after Inhaled Delivery in Sheep: A Viable Approach to Treating Idiopathic Pulmonary Fibrosis.
PublishedSeptember 10, 2019 Category Partner News Santhera Announces Publication of Phase I Clinical Data with POL6014 in Journal of Cystic Fibrosis
PublishedAugust 14, 2019 Category Publications Making Concentrated Antibody Formulations Accessible for Vibrating-Mesh Nebulization.